4-Amino-1-methylpiperidine | CAS:41838-46-4

We serve 4-Amino-1-methylpiperidine CAS:41838-46-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-Amino-1-methylpiperidine

Chemical Name:4-Amino-1-methylpiperidine
CAS.NO:41838-46-4
Synonyms:4-Amino-1-methylpiperidine
1-methyl-4-piperidinamine
1-methyl-piperidin-4-ylamine
1-methylpiperidin-4-ylamine
1-methyl-4-amino-piperidine
4-amino-N-methylpiperidine
 
Physical and Chemical Properties:
Density 0.9±0.1 g/cm3
Boiling Point 141.0±8.0 °C at 760 mmHg
Melting Point 203-207
Molecular Formula C6H14N2
Molecular Weight 114.189
Flash Point 39.2±13.6 °C
 
Specification:
Appearance:Colorless to pale yellow transparent liquid
Assay:≥98.0%
Other assay:≤0.5%
Moisture:≤1.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Pharmaceutical intermediate.



Contact us for information like 4-Amino-1-methylpiperidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-amino-N-methylpiperidine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-methyl-4-piperidinamine Use and application,1-methylpiperidin-4-ylamine technical grade,usp/ep/jp grade.


Related News: Vietnam recently barred almost all flights to and from mainland China, Hong Kong and Macau until May 1, according to the United States Federal Aviation Administration.N-(biphenyl-4-yl)-N-(4'-broMobiphenyl-4-yl)-9,9-diMethyl-9H-fluoren-2-amine manufacturer Retrogenix’s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding.2-Bromo-2'-fluoroacetophenone supplier Retrogenix’s extensive library of human proteins make it uniquely placed for assessing candidate antibodies for target binding.(Chloromethyl)trichlorosilane vendor At the same time, due to the relatively late development of the bulk drug business in China, most of the established bulk drug companies are currently in the field of commonly used generic drug bulk drugs. Stand up.ICIG will also supply materials needed for the manufacture of other treatments in earlier stages of development, including neo-GAA, currently in preclinical development as a potential next-generation Pompe disease therapy.